Exploiting an epigenetic switch in adrenal cancer.

Humans Enhancer of Zeste Homolog 2 Protein / genetics Adrenal Cortex Neoplasms / genetics Enzyme Inhibitors / pharmacology Epigenesis, Genetic

Journal

Science signaling
ISSN: 1937-9145
Titre abrégé: Sci Signal
Pays: United States
ID NLM: 101465400

Informations de publication

Date de publication:
18 07 2023
Historique:
medline: 21 7 2023
pubmed: 18 7 2023
entrez: 18 7 2023
Statut: ppublish

Résumé

EZH2 inhibitors may slow the progression of an aggressive form of adrenocortical cancer.

Identifiants

DOI: 10.1126/scisignal.adj7203 PMID: 37463243
pubmed: 37463243
doi: 10.1126/scisignal.adj7203
doi:

Substances chimiques

Enhancer of Zeste Homolog 2 Protein EC 2.1.1.43
Enzyme Inhibitors 0

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadj7203

Auteurs

Leslie K Ferrarelli (LK)

Science Signaling, AAAS, Washington, DC 20005, USA. Email: lferrare@aaas.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Exploiting an epigenetic switch in adrenal cancer.
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › Protéines de répression › Protéines du groupe Polycomb › Complexe répresseur Polycomb-2 › Protéine-2 homologue de l'activateur de Zeste › Exploiting an epigenetic switch in adrenal cancer.
questionsmedicales.fr › Maladies endocriniennes › Tumeurs des glandes endocrines › Tumeurs de la surrénale › Tumeurs corticosurrénaliennes › Exploiting an epigenetic switch in adrenal cancer.
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Mécanismes moléculaires de l'action pharmacologique › Antienzymes › Exploiting an epigenetic switch in adrenal cancer.
questionsmedicales.fr › Phénomènes génétiques › Régulation de l'expression des gènes › Épigenèse génétique › Exploiting an epigenetic switch in adrenal cancer.